Ali Salavati, MD, MPH Profile
Ali Salavati, MD, MPH

@AliSalavatiMD

Followers
233
Following
1K
Statuses
156

Nuclear Radiologist @UCLA @UCLAHEALTH #CancerImaging #NuclearMedicine #Theranostics

Los Angeles, CA
Joined December 2019
Don't wanna be here? Send us removal request.
@AliSalavatiMD
Ali Salavati, MD, MPH
4 days
RT @DrChoueiri: And NOW, TOP 5 PROSTATE CANCER trials of 2024! 1) The ARANOTE trial shows darolutamide + ADT improves rPFS in mHSPC by 46%…
0
173
0
@AliSalavatiMD
Ali Salavati, MD, MPH
22 days
RT @VPrasadMDMPH: AI will do a lot of good things. But it won't cure cancer. Here are a few reasons why 1. AI is trained on the best avail…
0
239
0
@AliSalavatiMD
Ali Salavati, MD, MPH
3 months
RT @APCCC_Lugano: Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric…
0
12
0
@AliSalavatiMD
Ali Salavati, MD, MPH
5 months
RT @CalaisJeremie: Happy to offer our patients our new trials of LuPSMA therapy FLEX MRT NCT06216249 and RE-LuPSMA NCT06288113. Thanks @No
0
12
0
@AliSalavatiMD
Ali Salavati, MD, MPH
5 months
RT @AJR_Radiology: A radiology department’s clinical implementation of a widely used AI triage system failed to improve radiologists’ accur…
0
27
0
@AliSalavatiMD
Ali Salavati, MD, MPH
8 months
Tweet media one
0
39
0
@AliSalavatiMD
Ali Salavati, MD, MPH
10 months
RT @Dr_K_Rahbar: PROSTest: a groundbreaking multigenomic liquid biopsy for prostate cancer detection in whole blood. the PROSTest exhibited…
0
2
0
@AliSalavatiMD
Ali Salavati, MD, MPH
11 months
0
4
0
@AliSalavatiMD
Ali Salavati, MD, MPH
1 year
RT @JournalofNucMed: A game changer! Pluvicto's big splash gets an early preview: #NuclearMedicine #ProstateCancer
0
11
0
@AliSalavatiMD
Ali Salavati, MD, MPH
1 year
RT @SNM_MI: CMS has removed the NCD for beta-amyloid PET scans, broadening access for Alzheimer's and neurodegenerative disease patients, g…
0
9
0
@AliSalavatiMD
Ali Salavati, MD, MPH
1 year
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
5
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
RT @thomashopemd: rh-PSMA-7.3 is now FDA approved for initial staging and biochemical recurrent. Third agent on the block! Approveed with…
0
25
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
RT @CalaisJeremie: You want to learn how to do PSMA PET imaging and therapy ? Save the Date for the UCSF-UCLA PSMA Conference on January 18…
0
9
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
RT @SNMMI_CIC: 1. For the second @SNMMI_CIC social media case, Drs. Steve Cho and Matthew Larson from @UWMadison present a case of cardiac…
0
5
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
RT @SNMMI_CIC: 1. We would like to announce the @SNMMI_CIC social media cases. These will be cases that highlight the complementary role o…
0
3
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
RT @CzerninJohannes: Getting there! Operational in June of 2023. The UCLA Ahmanson Theranostics Center
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
11
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
RT @aamalayeri: Almost everyone in the radiology community knows this, yet these companies are popping up left and right. A useless test…
0
3
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
RT @DrMHofman: Saw another patient this week misclassified as progression on DOTATATE PET/CT when the change was likely due to commencement…
0
41
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
@alborzsherafati Congratulations 👏
0
0
0
@AliSalavatiMD
Ali Salavati, MD, MPH
2 years
RT @DrMHofman: 1/ #LuTectomy #EAU23 Game Changing Session: first use of Lu-177 PSMA-617 first-line in patients with high-risk localised N0/…
0
70
0